The Safety Controls & Devices IPO allotment status has been released, and shares have been…
Speciality Medicines IPO Allotment Status 2026
The allotment status of the Speciality Medicines IPO is expected to be finalized on March 25, 2026. Investors who applied for this SME IPO can check whether they have received shares through official platforms such as the BSE website and the registrar, Skyline Financial Services.
The IPO witnessed decent demand and was fully subscribed by the final day of bidding, reflecting moderate investor interest.
How to Check Speciality Medicines IPO Allotment Status
Investors can check their IPO allotment status using the following methods:
1. Check on BSE Website
- Visit the BSE IPO allotment page
- Select “Equity” under issue type
- Choose “Speciality Medicines Ltd”
- Enter PAN or Application Number
- Click on “Search”
This is one of the easiest ways to verify your IPO application status
2. Check on Skyline Financial Services (Registrar)
- Visit the Skyline Financial Services IPO page
- Select the company name
- Enter PAN / DP ID / Application Number
- Click on “Search”
The registrar provides the most accurate and fastest allotment updates.
3. Alternative Methods
You can also check allotment status through:
- NSE IPO allotment page
- IPO registrar platforms or apps
These platforms allow investors to track allotment using basic details like PAN or Demat ID.
Speciality Medicines IPO Details
- Issue Size: ₹29.14 crore
- Price Band: ₹117 – ₹124 per share
- Lot Size: 1,000 shares
- IPO Type: SME IPO
- Registrar: Skyline Financial Services
The company focuses on marketing and distributing specialty pharmaceutical products used for treating complex and chronic diseases.
Speciality Medicines IPO Overview
The Speciality Medicines IPO is an SME offering that aims to raise approximately ₹29.14 crore through a fresh issue of shares. The company operates in the pharmaceutical distribution space, focusing on specialty and critical-care medicines used for treating chronic and complex health conditions.
The IPO opened on March 20, 2026, and closed on March 24, 2026, receiving decent investor interest by the end of the subscription period. The price band for the issue was set at ₹117 to ₹124 per share, with a minimum lot size of 1,000 shares.
The allotment status is expected to be finalized on March 25, 2026, and the shares are likely to be listed on the BSE SME platform on March 30, 2026. The IPO registrar is Skyline Financial Services, which will manage the allotment and refund process.
Overall, the IPO attracted moderate demand, making allotment chances dependent on category-wise subscription levels, especially in the retail segment.
Related Posts
